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ABSTRAK
Latar belakang: pasien rawat inap dengan penyakit medis berisiko terjadinya trombosis vena dalam (TVD) 
dan akibatnya terjadi peningkatan risiko mortalitas. Di Indonesia, terdapat disparitas fasilitas pelayanan medis 
dan terbatasnya data insidens TVD di negara beragam etnisitas dan geografi yang unik dengan populasi yang 
besar ini. Maka, kami mengeksplorasi insidens TVD dan skor Wells rerata pada pasien rawat inap dengan 
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penyakit medis yang berisiko tinggi. Metode: pada studi registri multisenter, prospektif, observasional di 
Indonesia, subyek (usia > 40 tahun) dengan penyakit medis akut (seperti kanker, infeksi akut, atau penyakit 
respiratori berat) dan tirah baring total selama > 3 hari diikutsertakan dalam studi ini antara Januari 2016 
dan November 2017. Data mengenai riwayat penyakit, skor Wells, diagnosis TVD dengan compression 
ultrasonography (CUS) diambil. Insidens TVD dianalisa pada kelompok eligible dan evaluable. Data dianalisa 
menggunakan metode deskriptif. Hasil: dari 360 subyek, 334 dianalisa sebagai kelompok eligible. Compression 
ultrasonography tidak dapat dilakukan pada 26 subyek. Sehingga, 308 subyek yang menyelesaikan prosedur 
studi dianalisa sebagai kelompok evaluable. Etnis Jawa merupakan etnis terbanyak pada kelompok eligible 
dan obesitas merupakan riwayat medis tersering. Secara keseluruhan, insidens TVD pada kelompok eligible 
dan evaluable sebesar masing – masing 37,1% dan 40,3%. Skor Wells rerata (SB) sebesar 3 (1,20) dan durasi 
tirah baring rerata selama 9 (6,89) hari. Kesimpulan: studi ini menemukan insidens TVD yang tinggi pada 
pasien penyakit medis di Indonesia dan memberikan masukan baru mengenai kewaspadaan TVD di Indonesia.
Kata kunci: trombosis vena dalam, insidens, penyakit medis.
ABSTRACT
Background: medically ill hospitalized patients are at risk of deep vein thrombosis (DVT) and consequentially 
have high chances of mortality. In Indonesia, there is disparity in healthcare facility and data on incidence of 
DVT in this multi-ethnic, geographically unique country with large population are limited. Hence, we determined 
the incidence of DVT and evaluated mean Wells score among medically ill hospitalized persons at increased 
risk. Methods: in this multicenter, prospective, observational registry in Indonesia, subjects (age >40 years) 
with acute medical illness (like cancer, acute infection, or severe respiratory disease) confined to bed for >3 
days were enrolled between January 2016 and November 2017. Data for medical history, Wells score, and DVT 
diagnosis with compression ultrasonography (CUS) were recorded. DVT incidence was analyzed in eligible and 
evaluable groups. Data were analyzed by descriptive method. Results: out of 360 subjects enrolled, 334 were 
included in the eligible group for analyses. CUS could not be performed in 26 subjects. Thus, 308 subjects who 
completed the study were included in the evaluable group. Javanese were predominant in the eligible group 
and obesity was the most common medical history at presentation. Overall, incidence of DVT in eligible and 
evaluable patients was 37.1% and 40.3%, respectively. Mean (SD) Wells score and bedridden days were 3 (1.20) 
and 9 (6.89), respectively. Conclusion: this study indicated that the incidence of DVT is high in medically ill 
patients in Indonesia and will provide new insights and awareness about DVT in Indonesia.
Keywords: deep vein thrombosis, incidence, medically ill.
INTRODUCTION
Venous thromboembolism (VTE) is a 
common cause of preventable morbidity and 
mortality in medically ill patients1, and deep vein 
thrombosis (DVT) with pulmonary embolism 
(PE) is associated with high mortality rate.2 The 
frequency of DVT without prophylaxis varies 
from 10% to 26%. PE is accountable for up to 
10% in-hospital mortality, and 75% of fatal PE 
cases occur in medically ill patients.3
Owing to the lack of robust literature on 
Asian population, it was earlier believed that the 
incidence of VTE was higher in the Caucasian 
population.4 However, recent literature shows 
that Asian countries account for considerable 
global VTE-related burden and in terms of 
incidence, it is comparable to the West. The 
incidence of VTE in Asia is significant and 
rising among hospitalized medically ill patients.5 
Population-wide estimates of annual VTE rates 
in three Asian countries: Korea, Taiwan, and 
Hong Kong, range from 15% to 20% of the level 
recorded in the Western countries.6
Deep vein thrombosis can occur without 
symptoms, and affected patients may have 
minimal or atypical symptoms; even patients 
without thrombotic disorders may present 
clinical features suggestive of DVT. Only 25% 
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of those with DVT symptoms have a confirmed 
diagnosis of DVT on objective testing.7 The 
Wells scoring system is a clinical model widely 
used to assess the risk of DVT or PE in medically 
ill patients.8,9 The American College of Chest 
Physicians guidelines recommend initial testing 
with compression ultrasonography (CUS) for 
moderate and high pretest probability of the first-
time DVT of the lower extremity, especially if 
the patients have a comorbid condition associated 
with elevated D-dimer levels and are likely to 
have a false-positive result.10
One of the major challenges in medically 
ill patients at risk of VTE is significant 
underutilization of thromboprophylaxis.11-13 In 
Asia, underutilization of thromboprophylaxis 
is attributed to the notion that the incidence of 
VTE in Asians is lower than that in Caucasians.5 
A prospective disease registry in Indonesia 
documents underutilization of anticoagulants in 
acute medically ill patients at the risk of VTE.14 
Therefore, understanding the true incidence of 
VTE in Asian countries could improve the rate 
of VTE thromboprophylaxis in clinical practice.
Indonesia, a geographically unique country 
with large multi-ethnic population, has disparate 
healthcare facilities.15 To the best of our 
knowledge, no national-level data are available 
on DVT incidence in medically ill patients at 
high risk in Indonesia to help physicians evaluate 
and develop or adopt a standard-of-care for 
the benefit of patients with DVT. Hence, we 
conducted the IDENTIA registry to determine 
the incidence of DVT and evaluate the mean of 
Wells score among hospitalized medically ill 
patients at increased risk.
METHODS
IDENTIA was a multicenter prospective 
observational study conducted in Indonesia 
between January 2016 and November 2017. The 
study duration for each patient was approximately 
1–3 days, with either 1 or 2 visits depending on 
the Wells score of the patient.
Patients with Wells score ≥2 had two 
mandatory visits: first a baseline visit and 
second within 3 days for CUS to confirm DVT. 
The study was conducted as per the guiding 
principles detailed in the 18th World Medical 
Assembly (Declaration of Helsinki, 1964) and 
its subsequent amendments, the guidelines for 
Good Epidemiology Practice (US and European), 
and the applicable local regulations. This study 
has been approved by the Ethical Committee of 
Faculty of Medicine, Diponegoro University - 
Kariadi Hospital, Semarang (Reference number: 
346/EC/FK-RSDK/2015).
Subjects
Considering the incidence of DVT to be 15%3 
and assuming a dropout rate of 15%, 360 patients 
were required to ensure 95% confidence interval. 
This would allow a minimum of 306 evaluable 
patients from 12 centers (1 private general 
hospital, 10 government general hospitals, and 
1 cancer hospital) across Indonesia. The number 
and geographic distribution of centers and the 
number of patients included in this study were 
representative of the population in Indonesia.
Inclusion and Exclusion Criteria
Patients, >40 years of age; with acute illness 
such as heart failure New York Heart Association 
class III or IV, severe respiratory disease, 
stroke, acute infections, or cancer; completely 
immobilized and confined to bed for >3 days, 
willing to sign the informed consent; were 
included. Patients, with a history of coagulation 
disorders (e.g., hemophilia, antiphospholipid 
syndrome, von Willebrand’s disease, and 
thrombophilia); suffering from thrombocytopenia 
(platelet count <50000/µL on the day of signing 
informed consent); had undergone surgery; 
or had received antithrombotic drugs; or if 
pregnant; were excluded.
Data Collection and Analysis
At visit 1 (baseline visit): the informed 
consent was obtained, the eligibility criteria 
assessed, and the patient’s demographic data, 
reason for hospitalization, signs and symptoms 
of DVT, and Wells score were recorded. At visit 
2 (baseline visit–day 3): the signs and symptoms 
of DVT and diagnosis of DVT based on CUS 
were recorded.
The diagnosis of DVT was confirmed if 
one or more of the following criteria were 
observed during the CUS examination: lack of 
complete compressibility of vein; visualization 
of intraluminal thrombus with complete or partial 
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obstruction of the vein lumen; distention of the 
vein compared to the adjacent artery; abnormal 
venous Doppler signals, i.e., continuous non-
phasic flow, reduced or absent flow with distal 
augmentation, or no obtainable signal; and 
continuous, non-phasic flow in common femoral 
vein (CFV) unilaterally, with phasic flow in 
contralateral CFV, suggesting iliac vein outflow 
obstruction, i.e., DVT of extrinsic compression.16
All radiologists who performed the CUS in this 
study were briefed to standardize the examination 
process. Patients who were eligible for visit 2, 
but could not complete the CUS examination and 
for whom no endpoint data were available, were 
considered as dropouts. Patients were stratified 
into two risk categories: “DVT likely” if the Wells 
score was ≥2 and “DVT unlikely” if the Wells 
score was <2. DVT was confirmed if the pretest 
probability was intermediate or high, and the CUS 
result was positive; when the clinical suspicion 
was low, and the CUS result was negative, 
presence of DVT was ruled out.
Statistical Analysis
Incidence of DVT was estimated in the 
eligible and evaluable patient groups. Eligible 
group consisted of all patients who enrolled in 
the registry. Evaluable group consisted of all 
patients who provided informed consent and 
completed visit 1 but did not qualify for visit 2; 
or those who qualified for visit 2 and completed 
CUS. Quantitative variables were presented 
using descriptive statistics, while qualitative 
variables were summarized using frequencies and 
percentages. Statistical analyses were performed 
using SAS (version 9.4; SAS Institute Inc., Cary, 
NC, United States). All data were analyzed in 
an explorative manner. Data were summarized 
using mean, median, standard deviation (SD), 
and range for continuous parameters; and counts 
and percentages for categorical parameters.
RESULTS
Of the 360 patients enrolled, 26 were not 
eligible. Among 334 eligible patients, CUS was 
not performed in 26 at visit 2 (due to patient’s 
limitations or for other reasons), and hence were 
excluded from the evaluable group (N=308). 
(Figure 1)
Eligible
n=334
Evaluable
n=308
Enrolled
N=360
Ineligible
n=26
Dropout
n=26
Figure 1. Subject disposition
Table 1. Demographic information and baseline 
characteristics
Variables Eligible subjects(N=334)
Age (year)
 - Mean (SD) 60.00 (11.34)
 - Median (min, max) 59 (40.0, 96.0)
Gender, n (%)
 - Men 153 (45.81)
 - Women 181 (54.19)
Height (cm)
 - N 325
 - Mean (SD) 159.00 (8.05)
Weight (kg)
 - N 317
 - Mean (SD) 53.00 (12.86)
BMI
 - N 317
 - Mean (SD) 21.00 (4.27)
Ethnicity, n (%)
 - Javanese 171 (51.20)
 - Bataknese 29 (8.68)
 - Balinese 22 (6.59)
 - Minangkabau 22 (6.59)
 - Chinese 20 (5.99)
 - Sundanese 16 (4.79)
 - Banjarnese 11 (3.29)
 - Buginese 8 (2.40)
 - Betawi 7 (2.10)
 - Makassar 7 (2.10)
 - Malay 5 (1.50)
 - Other*, n (%) 16 (4.79)
Past medical history, n (%)
 - Obesity 14 (4.2)
 - Hormone therapy 7 (2.1)
 - History of previous venous 
thromboembolism 2 (0.6)
 - Varicose vein 1 (0.3)
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The study comprised 45.81% (n=153) men 
and 54.19% (n=181) women; the mean (SD) 
age was 60.00 (11.34) years (Table 1). Javanese 
(n=171; 51.20%) was the major ethnic group 
followed by Bataknese (n=29; 8.68%). The most 
common past medical history was obesity (n=14; 
4.2%), and the most common acute illness was 
cancer (Table 1).
Incidence of DVT and Mean of Wells Score
Compression ultrasonograpgy (CUS) was 
performed in 268 (80.2% of eligible and 87.0% 
of evaluable population) patients with Wells 
score ≥2. Overall, 124 subjects had confirmed 
DVT (37.1% of eligible and 40.3% of evaluable 
Table 1. Demographic information and baseline 
characteristics
Variables Eligible subjects(N=334)
Diagnosis of medically ill subjects (N=334)**
 - Cancer 217
 - Acute infection 154
 - Severe respiratory disease 24
 - Stroke 19
 - Heart Failure NYHA Class III/IV 13
BMI, body mass index; max, maximum; min, minimum; 
n, total number of subjects; N, total number of eligible 
subjects; SD, standard deviation. Other*=Manado, 
Palembang, Flores, Melanesia, Ambonese, Dayak, 
Irian Jaya, Mongondow, Ternate, Toraja. **Each subject 
probably had more than 1 diagnosis.
Table 2. Incidence of DVT according to acute illnesses in eligible population
Diagnosis  
(Eligible subjects, N=334) DVT (N=124) Without DVT (N=184) Dropouts (N=26)
Cancer 92 104 21
Acute infection 50 91 13
Severe respiratory disease 5 19 0
Stroke 7 11 1
Heart Failure NYHA class III/IV 4 7 2
Each subject probably had more than 1 diagnosis
population). Most patients with DVT had either 
cancer or acute infection (Table 2). 
The mean (SD) Wells score was similar 
among the two groups: 3 (1.20) for eligible and 
3 (1.18) for the evaluable group. A Wells score of 
2 was most commonly noted among patients (144 
[43.1%] in the eligible group and 132 [42.9%] 
patients in the evaluable group). The highest 
Wells score of 7 was noted in 2 (0.6%) patients 
from the eligible and in 1 (0.3%) patient in the 
evaluable group (Table 3).
Data on incidence of DVT when stratified 
by Wells score, indicated a probable trend with 
increasing DVT incidence with a corresponding 
increase in Wells score 2 to 5 (Table 4). 
Duration of Immobilization and Incidence of 
DVT in Eligible Group
During hospitalization, patients were 
immobile for a minimum of 2 days and a 
maximum of 38 days. The average duration of 
the patients’ confinement to the hospital bed 
Table 3. Two-level DVT Wells score in the evaluable group
Evaluable 
(N=308)
Wells Score
N 308
Mean (SD) 3.00 (1.18)
Median (min, max) 2 (1.0, 7.0)
Clinical probability simplified score, n (%)
DVT likely (Wells score ≥2) 268 (87.0)
DVT unlikely (Wells score <2) 40 (13.0)
Wells score, n (%)
 - 1 40 (13.0)
 - 2 132 (42.9)
 - 3 80 (26.0)
 - 4 30 (9.7)
 - 5 18 (5.8)
 - 6 7 (2.3)
 - 7 1 (0.3)
DVT, deep vein thrombosis; max, maximum; min, 
minimum; n, total number of patients; N, total number of 
evaluable patients; SD, standard deviation
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was 9 (SD 6.89) days. Majority of the patients 
were immobile for 4 days and the incidence of 
DVT among those patients was 40.2% (35/87) 
(Table 5).
Signs and Symptoms of DVT at Visit 1 and 
Visit 2 in Eligible Group
Overall, 40.1% (n/N=134/334) and 34.3% 
(n/N=37/108) patients at visit 1 and visit 2, 
respectively, had at least 1 sign or symptom of 
DVT. At both the visits, the most common sign 
and symptom was pitting edema confined to 
the symptomatic leg. Other common signs and 
symptoms noted at both the visits were entire leg 
swelling, calf swelling of at least 3 cm larger than 
asymptomatic side, localized tenderness or pain 
along the distribution of deep venous system, 
erythema of the symptomatic leg, and collateral 
superficial veins (non-varicose) (Table 6).
Signs and Symptoms of DVT and CUS 
Results in Eligible Group
Out of 124 patients with positive CUS, 50 
(40.3%) did not have any sign and symptom of 
DVT. On the other hand, out of 144 (43.1%) 
patients with negative CUS, 45 (31.3%) had 
signs and symptoms of DVT.
Correlation Between Past Medical History 
and DVT Incidence in Eligible Group
There was no statistically significant 
correlation between the past medical history 
and the incidence of DVT. The incidence of 
DVT was 6.5% (8/124) in subjects with history 
of obesity (Table 7).
Table 4. Incidence of DVT among patients with Wells score ≥2
Wells score
DVT incidence among medically ill patients at increased risk
Eligible=294 Evaluable=268
N n (%) N n (%)
2 144 42 (29.2) 132 42 (31.8)
3 86 39 (45.3) 80 39 (48.8)
4 34 21 (61.8) 30 21 (70.0)
5 20 16 (80.0) 18 16 (88.9)
6 8 5 (62.5) 7 5 (71.4)
7 2 1 (50.0) 1 1 (100.0)
Overall 294 124 (37.1) 268 124 (40.3)
DVT, deep vein thrombosis; n, total number of patients with incidence; N, total number of patients in each category. Incidence 
rate: Number of patients whose Wells score was ≥2 and CUS result was positive divided by the number of available patients 
in each category. Percentage will be calculated from total number of patients available in each category as denominator.
Correlation Between Past Medical History 
and Wells Score in Eligible Group
There was no statistically significant 
correlation between the past medical history 
and the Wells score. Of the 294 patients, who had 
Wells score ≥2, 13 (4.4%) patients had a history 
of obesity, while obesity was present in only 1 
(2.5%) of the 40 patients from the Wells score 
1 group. Overall, patients with medical history 
were mostly found in Wells score ≥2 group than 
in the Wells score 1 group (Table 8).
DISCUSSION
This study showed a high incidence of DVT 
among medically ill patients in Indonesia who 
are immobile (confined to bed for >3 days) and 
at an increased risk of VTE. In another study, 
VTE developed in 11% of patients who were 
at high risk of thrombosis and did not receive 
thromboprophylaxis.11 The incidence of DVT 
was 40.3% and is relatively higher than that 
reported in a recent systematic literature review 
including several Asian countries.6 This finding 
might be explained by inclusion of high-risk 
medically ill patients. Cancer, congestive 
heart failure, chronic obstructive pulmonary 
disease are some of the known high risk factors 
associated with DVT.17 Other factors, such as 
high number of patients with Wells score 2 or 
more, relatively older patients (mean age: 60 
years), long duration of immobilization (mean 
duration of confinement to bed: 9 days), and the 
criteria of diagnosis using CUS may have also 
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contributed to the high incidence of DVT.
The criteria for high-risk DVT used in 
the inclusion criteria of this registry is in line 
with the Padua scoring system, a validated risk 
assessment model to identify subjects at potential 
risk of VTE. Reduced mobility for >3 days 
and acute medical condition are the 2 factors 
incorporated in this registry from the Padua 
model to categorize high-risk subjects.11
In this study, the Wells scoring system is 
used to assess the probability of DVT, and CUS 
was performed for diagnosing DVT, whereas, 
the D-dimer test was not performed as it is 
considered to have a high negative predictive 
value and is useful in ruling out DVT. The mean 
Wells score in our study is consistent with the 
result of a similar hospital-based prospective 
study that reported a score of 3.58 in subjects 
with clinical suspicion of DVT.18 The diagnosis 
of DVT was positive in both eligible and 
evaluable groups and there was an indication of 
corresponding increase in DVT with increasing 
Wells score. This trend was similar to the linear 
trend observed between incidence of DVT and 
Wells score in an earlier study that assessed the 
risk of DVT in patients with trauma, indicating 
that Wells score is a valid pretest tool for risk 
stratification of DVT.19
A strong association between immobility 
and risk of venous thrombosis has been widely 
reported.20,21 Confinement to bed for >3 days is 
one of the risk factors for acute DVT.22 In this 
study, the mean duration of confinement to bed 
during hospitalization was 9 days. Most of the 
patients had an immobilization period of 4 days, 
and the incidence of DVT among these patients 
was >40%, signifying the risk status. 
The most common signs and symptoms 
observed in this registry were pitting edema 
and swelling in the entire symptomatic leg; 
both are established clinical variables to assess 
the probability of DVT.23 In the eligible group 
in our study, out of 124 patients with positive 
CUS, 59.7% had signs and symptoms of DVT, 
while the remaining 40.3% showed no signs 
and symptoms. An earlier study reported 36.4% 
confirmed cases among those having signs 
and symptoms of DVT assessed by duplex 
ultrasonography.24 In our study, out of 144 
eligible patients with negative CUS, 31.3% had 
signs and symptoms of DVT. This could be 
suggestive of other clinical conditions having 
similar signs and symptoms. In general, Wells 
Table 5. Duration of immobilization in current hospitalization 
and incidence of DVT (eligible group)
Duration of 
immobilization
(days)
DVT Incidence among medically 
ill patients at increased risk
Eligible
N=334 n (%)
2 3 2 (66.7)
3 9 4 (44.4)
4 87 35 (40.2)
5 43 14 (32.6)
6 28 8 (28.6)
7 17 5 (29.4)
8 18 5 (27.8)
9 27 8 (29.6)
10 8 2 (25.0)
11 9 5 (55.6)
12 13 6 (46.2)
13 10 3 (30.0)
14 9 4 (44.4)
15 5 1 (20.0)
16 6 3 (50.0)
17 3 1 (33.3)
18 2 0 (0)
19 5 2 (40.0)
20 3 2 (66.7)
21 4 1 (25.0)
22 3 2 (66.7)
23 3 2 (66.7)
24 1 0
25 5 4 (80.0)
26 1 0 (0)
28 1 0 (0)
30 4 1 (25.0)
31 1 0
32 2 1 (50.0)
33 1 1 (100.0)
34 1 1 (100.0)
36 1 0 (0)
38 1 1 (100.0)
TOTAL 334 124 (37.1)
DVT, deep vein thrombosis; n: total number of patients 
with incidence; N, total number of patients having duration 
of immobilization (days). Incidence rate: Number of 
patients whose Wells score was ≥2 and CUS result was 
positive divided by the number of available patients in 
each category.
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score of >2 can help predict patients who are 
at increased probability of DVT, especially if 
Doppler ultrasonography (USG) is not available. 
Patients with Wells score >2 and a positive result 
on Doppler USG should receive treatment. 
Hence, patients with signs and symptoms should 
be further diagnosed with Doppler USG since 
there are several other diseases with similar signs 
and symptoms of DVT.
Among the risk factors associated with DVT 
in medically ill patients, a previous history of 
VTE is one of the strongest predictors.25 The 
risk of DVT also substantially increases among 
patients diagnosed with varicose veins26 and in 
those exposed to hormonal therapy.27 In addition, 
evidence suggests that subjects with obesity 
(body mass index [BMI] ≥30 kg/m2) are at 2-fold 
higher risk of developing DVT than subjects 
without obesity.28 In this study, there was no 
statistically significant correlation between the 
past medical history and the Wells score or DVT 
incidence. The very low number of patients with 
Table 6. Details of signs and symptoms of DVT at Visit 1 and Visit 2 (eligible group)
Eligible (N=334)
Visit 1 Visit 2
The subject was not eligible for Visit 2*, n (%) - 40 (12.0)
The subject was eligible for Visit 2 as per all enrolled/evaluable 
population,* n (%) - 294 (88.0)
 - Visit 2 was not performed on the same day of Visit 1 - 108 (36.7)
 - Visit 2 performed on the same day of Visit 1 - 170 (57.8)
 - Not done - 15 (5.1)
 - Missing† - 1 (0.3)
Total no. of subjects with any sign/symptom,‡ n (%) 134 (40.1) 37 (34.3)
Total no. of subjects without any sign/symptom,‡ n (%) 200 (59.9) 71 (65.7)
Pitting edema confined to the symptomatic leg, n (%)
 - Yes 97 (29.0) 30 (10.2)
 - No 237 (71.0) 78 (26.5)
Entire leg swelling, n (%)
 - Yes 84 (25.15) 24 (8.2)
 - No 250 (74.85) 84 (28.6)
Calf swelling at least 3 cm larger than asymptomatic side, n (%)
 - Yes 35 (10.48) 9 (3.1)
 - No 299 (89.52) 99 (33.7)
Localized tenderness or pain along the distribution of deep venous 
system, n (%)
 - Yes 29 (8.68) 10 (3.4)
 - No 305 (91.32) 98 (33.3)
Erythema of the symptomatic leg, n (%)
 - Yes 11 (3.3) 3 (1.0)
 - No 323 (96.7) 105 (35.7)
Collateral superficial veins (non-varicose), n (%)
 - Yes 2 (0.6) 2 (0.7)
 - No 332 (99.4) 106 (36.1)
Cyanosis of the symptomatic leg, n (%)
 - Yes 2 (0.6) 0 (0)
 - No 332 (99.4) 108 (36.7)
n, total number of patients; N, total number of patients in eligible/evaluable group. *Percentage was calculated based on 
eligible/evaluable group. †No data on sign and symptoms of DVT at Visit 2. ‡Percentage was calculated based on patients 
for whom Visit 2 was not performed on the same day of Visit 1. Details of signs and symptoms of DVT to be filled if Visit 1 
and Visit 2 were not performed on the same day.
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a past medical history in this registry makes 
it difficult to establish an association with 
occurrence of DVT.
Limitations
In this study, CUS was used for detection 
of DVT, which is an effective and noninvasive 
procedure, but may not be superior to contrast 
venography. Though regarded as a gold standard, 
contrast venography has inherent risks and 
limitations and is not routinely used and not 
widely available in Indonesia. For subjects with 
Wells score 2 or more but with negative finding on 
CUS, no serial CUS examination was performed 
during the study. There might be a high possibility 
of increased number of DVT cases being detected 
if CUS was performed more than once in this 
population.
Table 7. Correlation between past medical history and DVT incidence (eligible group*)
DVT (N=124) Without DVT (N=144) p-Value
Obesity, n (%)
 - Yes 8 (6.5) 4 (2.8) 0.2352
 - No 116 (93.5) 140 (97.2)
Hormone therapy, n (%)
 - Yes 3 (2.4) 4 (2.8) 1.0000
 - No 121 (97.6) 140 (97.2)
History of previous venous 
thromboembolism, n (%)
 - Yes 2 (1.6) 0 (0) 0.2131
 - No 122 (98.4) 144 (100.0)
Varicose vein, n (%)
 - Yes 0 (0) 0(0) 0.2131
 - No 124 (100.0) 144 (100.0)
DVT, deep vein thrombosis; n, total number of patients; N, total number of eligible patients. Percentage was calculated 
from total number of patients available in each category. p-Value was computed using Chi-square/Fisher test to check the 
difference of past medical history among DVT incidences. *Data were missing for 26 eligible patients, which meant that 
these subjects were eligible for Visit 2, but Visit 2 was not performed for some reason.
Table 8. Correlation between past medical history and Wells score (eligible group)
Wells score 1 (N=40) Wells score ≥2 (N=294) p-Value
Obesity, n (%)
 - Yes 1 (2.5) 13 (4.4) 1.0000
 - No 39 (97.5) 281 (95.6)
Varicose vein, n (%)
 - Yes 1 (2.5) 0 (0) 0.1198
 - No 39 (97.5) 294 (100.0)
Hormone therapy, n (%)
 - Yes 0(0) 7 (2.4) 1.0000
 - No 40 (100.0) 287 (97.6)
History of previous venous 
thromboembolism, n (%)
 - Yes 0 (0) 2 (0.7) 1.0000
 - No 40 (100.0) 292 (99.3)
n, total number of patients; N, total number of eligible patients. Percentage was calculated from total number of patients 
available in each category. p-Value was computed using Chi-square/Fisher test to check the association between past 
medical history among Wells scores.
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CONCLUSION
IDENTIA registry, to the best of our 
knowledge, is the first of its kind study to 
determine the incidence of DVT among 
medically ill patients at an increased risk of DVT 
in Indonesia. In this study, Wells score together 
with CUS was used for diagnosing DVT; the high 
incidence reported herewith indicates that DVT 
is common among medically ill patients at risk 
of VTE in Indonesia. These findings would help 
increase awareness on the risk of DVT among 
healthcare professionals and facilitate the use 
of appropriate prophylaxis necessary to prevent 
death and other VTE-related complications 
among medically ill patients hospitalized in 
Indonesia.
ADDENDUM
K. L. Tambunan is the national coordinator 
and principle investigator of the study. J. 
Pandelaki did data acquisition and briefed all 
radiologists involved in this study regarding the 
study-specific procedures (Doppler USG). All 
remaining authors are principal investigators in 
the study. All authors were responsible for the 
interpretation of analyses and critical revision 
of the manuscript. 
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